[1]张民霞.血液灌流联合血液透析治疗肾功能衰竭难治性高血压的效果[J].医学信息,2019,32(15):109-110,115.[doi:10.3969/j.issn.1006-1959.2019.15.035]
　ZHANG Min-xia.Effect of Hemoperfusion Combined with Hemodialysis on Refractory Hypertension with Renal Failure[J].Journal of Medical Information,2019,32(15):109-110,115.[doi:10.3969/j.issn.1006-1959.2019.15.035]
点击复制

血液灌流联合血液透析治疗肾功能衰竭难治性高血压的效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年15期
页码:
109-110,115
栏目:
临床研究
出版日期:
2019-08-01

文章信息/Info

Title:
Effect of Hemoperfusion Combined with Hemodialysis on Refractory Hypertension with Renal Failure
文章编号:
1006-1959（2019）15-0109-03
作者:
张民霞
天津市静海区医院血透室，天津 301600
Author(s):
ZHANG Min-xia
Hemodialysis Room,Jinghai Hospital,Tianjin 301600,China
关键词:
血液灌流; 血液透析; 肾功能衰竭难治性高血压
Keywords:
Key words：Hemoperfusion; Hemodialysis; Renal failure refractory hypertension
分类号:
R544.1
DOI:
10.3969/j.issn.1006-1959.2019.15.035
文献标志码:
A
摘要:
目的 探讨血液灌流联合血液透析对肾功能衰竭难治性高血压的治疗效果。方法 选取2017年10月~2019年2月我院收治的肾功能衰竭难治性高血压患者168例，随机分为对照组和研究组，每组84例。对照组应用血液透析治疗，研究组应用血液灌流联合血液透析治疗，比较两组治疗前后血压改善情况、肾素（PRA）、血管紧张素Ⅱ（ATⅡ）水平变化。结果 治疗后，两组收缩压、舒张压、平均动脉压均低于治疗前，差异有统计学意义（P＜0.05）；研究组收缩压、舒张压、平均动脉压均低于对照组[（145.37±14.54）mmHg vs（185.25±18.46）mmHg]、[（76.26±5.72）mmHg vs（107.51±9.27）mmHg]、[（100.47±9.39）mmHg vs（143.52±11.74）mmHg]，差异有统计学意义（P＜0.05）。治疗后，两组PRA、ATⅡ水平均低于治疗前，差异有统计学意义（P＜0.05）；研究组PRA、ATⅡ水平低于对照组[（1.05±0.36）ng/L vs（1.88±0.57）ng/L]、[（91.31±13.47）ng/L vs（170.54±20.66）ng/L]，差异有统计学意义（P＜0.05）。结论 血液灌流联合血液透析治疗肾功能衰竭难治性高血压效果理想，可有效控制高血压症状，改善患者PRA、ATⅡ水平。
Abstract:
Abstract：Objective To investigate the therapeutic effect of hemoperfusion combined with hemodialysis on refractory hypertension with renal failure. Methods A total of 168 patients with renal failure and refractory hypertension admitted to our hospital from October 2017 to February 2019 were randomly divided into the control group and the study group, with 84 cases in each group. The control group was treated with hemodialysis. The study group was treated with hemoperfusion combined with hemodialysis. The blood pressure improvement, renin (PRA) and angiotensin II (ATII) levels were compared before and after treatment.Results After treatment, the systolic blood pressure, diastolic blood pressure and mean arterial pressure were lower than those before treatment,the difference was statistically significant (P<0.05). The systolic, diastolic, and mean arterial pressures of the study group were lower than those of the control group [(145.37±14.54) mmHg vs (185.25±18.46) mmHg], [(76.26±5.72) mmHg vs (107.51±9.27) mmHg], [(100.47±9.39) mmHg vs (143.52±11.74) mmHg], the difference was statistically significant (P<0.05). After treatment, the levels of PRA and ATII in the two groups were lower than those before treatment, the difference was statistically significant (P<0.05). The level of PRA and ATII in the study group was lower than that in the control group [(1.05±0.36) ng/L vs (1.88±0.57) ng/L], [(91.31±13.47) ng/L Vs (170.54±20.66) ng/L], the difference was statistically significant (P<0.05). Conclusion Hemoperfusion combined with hemodialysis is effective in the treatment of refractory hypertension with renal failure. It can effectively control the symptoms of hypertension and improve the levels of PRA and ATII.

参考文献/References:

[1]盛勇.血液灌流联合血液透析对肾功能衰竭难治性高血压影响[J].临床医药文献电子杂志,2017,4(11):1. [2]黄健,刘畅,闵亚丽,等.应用人体成分分析仪评估干体重对维持性血液透析患者顽固性高血压的影响[J].实用医学杂志,2017,33(10):1557-1559. [3]徐玉祥,范丽,孙巨军,等.血液透析联合血液灌流对血液透析患者难治性高血压的影响[J].临床医学,2013,33(10):15. [4]陈阳.血液灌流与血液透析联合对肾功能衰竭难治性高血压的影响观察[J].吉林医学,2018,39(2):261-262. [5]甘平,张南征.不同血液灌流频度对慢性肾功能衰竭所致难治性高血压的影响[J].医学临床研究,2013,30(1):90-92. [6]王海燕.肾脏病学[M].第3版.北京:人民卫生出版社,2008:34-38. [7]潘丽丽,曾思文.血液灌流联合血液透析治疗慢性肾功能衰竭患者的临床疗效[J].中外健康文摘,2012(43):254-255. [8]冯亚红,张姣,于小勇.血液透析联合血液灌流在难治性高血压治疗中的应用观察[J].陕西医学杂志,2015,41(7):911-912.

相似文献/References:

[1]李伟东,单 静,曹 翔,等.血液灌流联合血液滤过在重症胰腺炎患者中的疗效及预后影响研究[J].医学信息,2018,31(03):103.[doi:10.3969/j.issn.1006-1959.2018.03.033]
　LI Wei-dong,SHAN Jing,CAO Xiang,et al.Study on Curative Effect and Prognosis of Hemoperfusion Combined with Hemofiltration in Patients with Severe Pancreatitis[J].Journal of Medical Information,2018,31(15):103.[doi:10.3969/j.issn.1006-1959.2018.03.033]
[2]肖一红.组合型人工肾技术预防血液透析中低血压的效果观察[J].医学信息,2018,31(03):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
　XIAO Yi-hong.Effect of Combined Artificial Renal Technique in Preventing Hypotension in Hemodialysis[J].Journal of Medical Information,2018,31(15):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
[3]邹 鑫,刘秀娟,余燕燕.血液透析对MHD患者血清FGF-23水平与 钙磷代谢的影响[J].医学信息,2018,31(09):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
　ZOU Xin,LIU Xiu-juan,YU Yan-yan.Effect of Hemodialysis on Serum FGF-23 Level and Calcium and Phosphorus Metabolism in MHD Patients[J].Journal of Medical Information,2018,31(15):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
[4]王允彦.西那卡塞对维持性血液透析继发性甲状旁腺功能亢进患者FGF-23的影响[J].医学信息,2018,31(13):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
　WANG Yun-yan.Effect of Cinacalcet on FGF-23 in Patients with Secondary Hyperparathyroidism during Maintenance Hemodialysis[J].Journal of Medical Information,2018,31(15):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
[5]方海东,李 荣.血液透析滤过联合血液透析治疗慢性肾功能衰竭的效果观察[J].医学信息,2019,32(02):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
　FANG Hai-dong,LI Rong.Effect of Hemodiafiltration Combined with Hemodialysis on Chronic Renal Failure[J].Journal of Medical Information,2019,32(15):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
[6]蒋红利,刘 华,史珂慧,等.陕西省县级医院透析室建设项目培训效果评价[J].医学信息,2018,31(19):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
　JIANG Hong-li,LIU Hua,SHI Ke-hui,et al.Evaluation on Training Effect of Dialysis Room Construction Project in County Hospitals in Shaanxi Province[J].Journal of Medical Information,2018,31(15):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
[7]谢 华,周毅峰,甘晓庆,等.血液透析专用中心静脉导管封管液的研究[J].医学信息,2019,32(18):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
　XIE Hua,ZHOU Yi-feng,GAN Xiao-qing,et al.Research on Central Venous Catheter Sealing Fluid for Hemodialysis[J].Journal of Medical Information,2019,32(15):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
[8]李钦涛.不同剂量肝素在血液灌流治疗农药中毒中的应用[J].医学信息,2019,32(20):110.[doi:10.3969/j.issn.1006-1959.2019.19.032]
　LI Qin-tao.Application of Different Doses of Heparin in the Treatment of Pesticide Poisoning by Blood Perfusion[J].Journal of Medical Information,2019,32(15):110.[doi:10.3969/j.issn.1006-1959.2019.19.032]
[9]喻学娜.协同护理对终末期肾脏病血液透析患者自我护理能力及治疗依从性的影响[J].医学信息,2019,32(20):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
　YU Xue-na.Effect of Collaborative Nursing on Self-care Ability and Treatment Compliance of Hemodialysis Patients with End-stage Renal Disease[J].Journal of Medical Information,2019,32(15):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
[10]王艳霞.中药灌肠对尿毒症血液透析患者便秘、食欲减退及呕吐等不良反应的影响[J].医学信息,2022,35(17):88.[doi:10.3969/j.issn.1006-1959.2022.17.023]
　WANG Yan-xia.Effect of Traditional Chinese Herb Enema on Adverse Reactions of Constipation,Loss of Appetite and Vomiting in Uremic Hemodialysis Patients[J].Journal of Medical Information,2022,35(15):88.[doi:10.3969/j.issn.1006-1959.2022.17.023]
[11]魏昌林.血液透析联合血液灌流在终末期肾病患者治疗中的应用[J].医学信息,2019,32(13):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
　WEI Chang-lin.Application of Hemodialysis Combined with Blood Perfusion in the Treatment of Patients with End-stage Renal Disease[J].Journal of Medical Information,2019,32(15):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
[12]钟瑜辉.血液透析联合血液灌流治疗尿毒症的效果[J].医学信息,2019,32(21):108.[doi:10.3969/j.issn.1006-1959.2019.21.034]
　ZHONG Yu-hui.Effect of Hemodialysis Combined with Blood Perfusion on Uremia[J].Journal of Medical Information,2019,32(15):108.[doi:10.3969/j.issn.1006-1959.2019.21.034]
[13]唐 建,朱倩莹,刘 莉,等.血液透析联合血液灌流治疗尿毒症皮肤瘙痒症的疗效[J].医学信息,2020,33(01):118.[doi:10.3969/j.issn.1006-1959.2020.01.036]
　TANG Jian,ZHU Qian-ying,LIU Li,et al.Hemodialysis Combined with Hemoperfusion in the Treatment of Uremia and Skin Pruritus[J].Journal of Medical Information,2020,33(15):118.[doi:10.3969/j.issn.1006-1959.2020.01.036]
[14]孟凡丽.血液透析联合血液灌流对慢性肾衰竭患者血清炎性因子及免疫功能的影响[J].医学信息,2022,35(19):57.[doi:10.3969/j.issn.1006-1959.2022.19.015]
　MENG Fan-li.Effect of Hemodialysis Combined with Hemoperfusion on Serum Inflammatory Factors and Immune Function in Patients with Chronic Renal Failure[J].Journal of Medical Information,2022,35(15):57.[doi:10.3969/j.issn.1006-1959.2022.19.015]

更新日期/Last Update: 2019-08-01